Health
Olfactory and gustatory impairments in COVID‐19 patients: Role in early diagnosis and interferences by concomitant drugs – Ferraro – – British Journal of Clinical Pharmacology – Wiley Online Library – Wiley
Click on the article title to read more.
The COVID19 pandemic spread worldwide with over 38 million confirmed cases and more than 1 million deaths as of October 15, 2020. The clinical manifestations of SARSCoV2 infection range from asymptomatic to lifethreatening pneumonia, with the main symptoms being respiratory and gastrointestinal in nature. However, several patients report neurological symptoms including smell and taste impairments, such as anosmia, cacosmia, ageusia and dysgeusia.1 Although the spread of the disease has been favoured…
-
Noosa News23 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News16 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General16 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News8 hours agoNew playground equipment encourages children to learn through ‘risky play’